Skip to content

Comparison of Two Heart Treatment Methods (Drug-Coated Balloons and Drug-Coated Stents) in Patients Undergoing Angioplasty for Coronary Artery Disease

Drug-Eluting Balloons versus Drug-Eluting Stents in Coronary Interventions:A Retrospective Comparative Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108795
Enrollment
100
Registered
2026-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery

Interventions

Intervention1: Drug Eluting Balloon Angioplasty: Use of drug eluting balloon during percutaneous coronary intervention in patients with coronary artery disease. This is a retrospective analysis of pat

Sponsors

Rhythm Heart and Critical Care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18 years and above Patients who underwent percutaneous coronary intervention using either drug eluting balloon or drug eluting stent Patients diagnosed with coronary artery disease including stable angina unstable angina NSTEMI or STEMI Availability of complete clinical procedural and angiographic records Procedures performed at the study center within the defined study period

Exclusion criteria

Exclusion criteria: Patients with incomplete or missing clinical procedural or angiographic data Patients presenting with cardiogenic shock at the time of intervention Patients with concomitant structural heart disease requiring intervention Patients who underwent hybrid procedures involving both drug eluting balloon and drug eluting stent in the same lesion Patients with prior percutaneous coronary intervention to the same lesion during the study period

Design outcomes

Primary

MeasureTime frame
Incidence of major adverse cardiac events including all cause mortality myocardial infarction and target lesion revascularizationTimepoint: Baseline, 52 Weeks

Secondary

MeasureTime frame
Procedural success rate defined as successful completion of percutaneous coronary intervention without major complications, Residual stenosis after intervention measured on angiography, Incidence of periprocedural complications including bleeding vascular complications or arrhythmias, Individual components of major adverse cardiac events including all cause mortality myocardial infarction and target lesion revascularization,Timepoint: During procedure and at hospital discharge

Countries

India

Contacts

Public ContactRakhshanda Khan

Rhythm Heart and Critical Care

harshawardhanramteke7@gmail.com8369525334

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026